{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:02:24Z","timestamp":1791820944377,"version":"4.3.4"},"reference-count":93,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.2215\/cjn.03150509","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T21:44:41Z","timestamp":1258667081000},"page":"2013-2026","source":"Crossref","is-referenced-by-count":140,"title":["Cardiorenal Syndrome in Acute Decompensated Heart Failure"],"prefix":"10.2215","volume":"4","author":[{"given":"Mohammad","family":"Sarraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Schrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20230601","first-page":"e25","article-title":"American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"key":"R2-24-20230601","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","article-title":"Renal function, neurohormonal activation, and survival in patients with chronic heart failure","volume":"102","author":"Hillege","year":"2000","journal-title":"Circulation"},{"key":"R3-24-20230601","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/01.ASN.0000135121.81744.75","article-title":"Renal function, digoxin therapy, and heart failure outcomes: Evidence from the digoxin intervention group trial","volume":"15","author":"Shlipak","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R6-24-20230601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.07.067","article-title":"Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?","volume":"47","author":"Schrier","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R7-24-20230601","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"R8-24-20230601","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community","volume":"41","author":"Manjunath","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R10-24-20230601","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"ADHERE Scientific Advisory Committee and Investigators: Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"R11-24-20230601","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"ADHERE Scientific Advisory Committee and Investigators: High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J Card Fail"},{"key":"R12-24-20230601","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archinte.167.14.1493","article-title":"OPTIMIZE-HF Investigators and Hospitals: Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: Results of the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF)","volume":"167","author":"Fonarow","year":"2007","journal-title":"Arch Intern Med"},{"key":"R13-24-20230601","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","article-title":"Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology: The EuroHeart Failure survey program\u2014A survey on the quality of care among patients with heart failure in Europe","volume":"24","author":"Cleland","year":"2003","journal-title":"Eur Heart J"},{"key":"R14-24-20230601","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/archinte.165.18.2069","article-title":"The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998\u20132001","volume":"165","author":"Masoudi","year":"2005","journal-title":"Arch Intern Med"},{"key":"R15-24-20230601","first-page":"93","article-title":"Chronic kidney disease associated mortality in diastolic versus systolic heart failure: A propensity matched study","volume":"99","author":"Ahmed","year":"2007","journal-title":"Am J Cardiol"},{"key":"R16-24-20230601","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hfc.2008.03.008","article-title":"Epidemiology of chronic kidney disease in heart failure","volume":"4","author":"Ahmed","year":"2008","journal-title":"Heart Fail Clin"},{"key":"R17-24-20230601","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"R18-24-20230601","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ncpneph0673","article-title":"Cardiorenal versus renocardiac syndrome: Is there a difference?","volume":"3","author":"Schrier","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"R19-24-20230601","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.RES.4.1.85","article-title":"Evidence of the atrial location of receptors influencing urine flow","volume":"4","author":"Henry","year":"1956","journal-title":"Circ Res"},{"key":"R21-24-20230601","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.77.4.721","article-title":"Neurohormone interaction and adaptations in congestive heart failure","volume":"77","author":"Packer","year":"1988","journal-title":"Circulation"},{"key":"R22-24-20230601","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-113-2-155","article-title":"Body fluid volume regulation in health and disease: A unifying hypothesis","volume":"113","author":"Schrier","year":"1990","journal-title":"Ann Intern Med"},{"key":"R23-24-20230601","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198810203191606","article-title":"Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)","volume":"319","author":"Schrier","year":"1988","journal-title":"N Engl J Med"},{"key":"R24-24-20230601","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.hfc.2008.03.006","article-title":"Renal hemodynamic changes in heart failure","volume":"4","author":"Blankstein","year":"2008","journal-title":"Heart Fail Clin"},{"key":"R25-24-20230601","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N Engl J Med"},{"key":"R26-24-20230601","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Mechanisms of disease: Aldosterone in chronic heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med"},{"key":"R27-24-20230601","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.CIR.38.4.629","article-title":"Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion","volume":"38","author":"Kramer","year":"1968","journal-title":"Circulation"},{"key":"R28-24-20230601","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.CIR.33.1.43","article-title":"Norepinephrine stores and contractile force of papillary muscle from the failing human heart","volume":"33","author":"Chidsey","year":"1966","journal-title":"Circulation"},{"key":"R29-24-20230601","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"N Engl J Med"},{"key":"R30-24-20230601","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI113663","article-title":"Atrial natriuretic peptides inhibit conductive sodium uptake by rabbit inner medullary collecting duct cells","volume":"92","author":"Zeidel","year":"1988","journal-title":"JCI"},{"key":"R31-24-20230601","first-page":"F321","article-title":"Osmotic and nonosmotic control of vasopressin release","volume":"236","author":"Schrier","year":"1979","journal-title":"Am J Physiol"},{"key":"R32-24-20230601","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM198810273191705","article-title":"Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2)","volume":"319","author":"Schrier","year":"1988","journal-title":"N Engl J Med"},{"key":"R33-24-20230601","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.amjmed.2006.09.012","article-title":"Pathophysiology of volume overload in acute heart failure syndromes","volume":"119","author":"Chen","year":"2006","journal-title":"Am J Med"},{"key":"R34-24-20230601","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1054\/jcaf.2002.125289","article-title":"The prognostic importance of different definitions of worsening renal function in congestive heart failure","volume":"8","author":"Gottlieb Gottlieb","year":"2002","journal-title":"Card Fail"},{"key":"R35-24-20230601","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/01.CCM.0000296270.41256.5C","article-title":"Acute decompensated heart failure and the cardiorenal syndrome","volume":"36","author":"Liang","year":"2008","journal-title":"Crit Care Med"},{"key":"R36-24-20230601","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(88)91851-X","article-title":"Raised venous pressure: A direct cause of renal sodium retention in oedema?","volume":"1","author":"Firth","year":"1988","journal-title":"Lancet"},{"key":"R37-24-20230601","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJM197112022852305","article-title":"Tubular reabsorption of sodium ion: Influence of factors other than aldosterone and glomerular filtration rate","volume":"285","author":"Schrier","year":"1971","journal-title":"N Engl J Med"},{"key":"R38-24-20230601","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11897-008-0017-x","article-title":"Adenosine A1 antagonists and the cardiorenal syndrome","volume":"5","author":"Gottlieb","year":"2008","journal-title":"Curr Heart Fail Rep"},{"key":"R39-24-20230601","first-page":"e154","article-title":"ACC\/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society","volume":"112","author":"Fonarow","year":"2005","journal-title":"Circulation"},{"key":"R40-24-20230601","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ahj.2007.03.012","article-title":"Temporal trends in clinical characteristics, treatment and outcomes for heart failure hospitalizations, 2002 to 2004: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"153","author":"Fonarow","year":"2007","journal-title":"Am Heart J"},{"key":"R41-24-20230601","first-page":"1541","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial","volume":"287","author":"Shah","year":"2005","journal-title":"JAMA"},{"key":"R42-24-20230601","first-page":"671","article-title":"Candesartan in Heart Failure: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"13","author":"Hillege","year":"2006","journal-title":"CHARM investigators Circ"},{"key":"R43-24-20230601","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: A report from the OPTIMIZE-HF registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"JACC"},{"key":"R44-24-20230601","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.293.5.572","article-title":"Risk stratification for in-hospital mortality in acutely decompensated heart failure: Classification and regression analysis","volume":"293","author":"Fonarow","year":"2005","journal-title":"JAMA"},{"key":"R45-24-20230601","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933","article-title":"Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival. Results from the Outcomes of a Prospective Trial of Intravenous Milrinonoe for Exacerbations of Chronic Heart Failure (OPTIME-CHF)","volume":"1","author":"Klein","year":"2008","journal-title":"Cir Heart Fail"},{"key":"R46-24-20230601","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMoa010641","article-title":"Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure","volume":"345","author":"Drazner","year":"2001","journal-title":"N Engl J Med"},{"key":"R47-24-20230601","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/eurheartj\/ehl542","article-title":"Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: An analysis from the OPTIMIZE-HF registry","volume":"28","author":"Gheorghiade","year":"2007","journal-title":"Eur Heart J"},{"key":"R48-24-20230601","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCHEARTFAILURE.108.770834","article-title":"Blood urea nitrogen and serum creatinine. Not married in heart failure","volume":"1","author":"Schrier","year":"2008","journal-title":"Cir Heart Fail"},{"key":"R49-24-20230601","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1172\/JCI118162","article-title":"Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiac hypertrophy: Evidence for BNP as an \u201cemergency\u201d cardiac hormone against ventricular overload","volume":"96","author":"Nakagawa","year":"1995","journal-title":"J Clin Invest"},{"key":"R50-24-20230601","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1067\/mem.2002.121483","article-title":"B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea","volume":"39","author":"Harrison","year":"2002","journal-title":"Ann Emerg Med"},{"key":"R51-24-20230601","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mhj.2002.120152","article-title":"Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema","volume":"143","author":"Perna","year":"2002","journal-title":"Am Heart J"},{"key":"R52-24-20230601","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ahj.2007.01.027","article-title":"Relation between cardiac troponin I and mortality in acute decompensated heart failure","volume":"153","author":"You","year":"2007","journal-title":"Am H J"},{"key":"R53-24-20230601","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","article-title":"Cardiac troponin and outcome in acute heart failure","volume":"358","author":"Peacock","year":"2008","journal-title":"N Engl J Med"},{"key":"R54-24-20230601","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.73.2.257","article-title":"Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure","volume":"73","author":"Lee","year":"1986","journal-title":"Circulation"},{"key":"R55-24-20230601","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000165065.82609.3D","article-title":"Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study","volume":"111","author":"Klein","year":"2005","journal-title":"Circulation"},{"key":"R56-24-20230601","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/archinte.167.18.1998","article-title":"Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial","volume":"167","author":"Gheorghiade","year":"2007","journal-title":"Arch Intern Med"},{"key":"R57-24-20230601","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"R58-24-20230601","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial","volume":"219","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"R59-24-20230601","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"R60-24-20230601","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"R61-24-20230601","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.hfc.2008.03.005","article-title":"Anemia and cardiovascular risk in the patient with kidney disease","volume":"4","author":"Fishbane","year":"2008","journal-title":"Heart Fail Clin"},{"key":"R62-24-20230601","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","article-title":"Plasma cytokine parameters and mortality in patients with chronic heart failure","volume":"102","author":"Rauchhaus","year":"2000","journal-title":"Circulation"},{"key":"R63-24-20230601","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0735-1097(01)01470-X","article-title":"Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction","volume":"38","author":"Al-Ahmad","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R64-24-20230601","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(01)01248-7","article-title":"The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study","volume":"37","author":"Silverberg","year":"2000","journal-title":"J Am Coll Cardol"},{"key":"R65-24-20230601","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"R67-24-20230601","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10741-005-6129-4","article-title":"The cardiorenal syndrome: Lessons from the ADHERE database and treatment options","volume":"9","author":"Heywood","year":"2004","journal-title":"Heart Fail Rev"},{"key":"R68-24-20230601","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0002-9149(00)00705-0","article-title":"Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure","volume":"85","author":"Krumholz","year":"2000","journal-title":"Am J Cardiol"},{"key":"R69-24-20230601","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"296","author":"Gheorghiade","year":"2006","journal-title":"JAMA"},{"key":"R70-24-20230601","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"Am Coll Cardiol"},{"key":"R71-24-20230601","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1001\/jama.299.22.2656","article-title":"Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction","volume":"299","author":"Wang","year":"2008","journal-title":"JAMA"},{"key":"R72-24-20230601","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1357-2725(02)00306-0","article-title":"The brain renin-angiotensin system: Location and physiological roles","volume":"35","author":"McKinley","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"R73-24-20230601","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.jacc.2006.03.017","article-title":"Admission body temperature and mortality in elderly patients hospitalized for heart failure","volume":"47","author":"Brahmajee","year":"2006","journal-title":"J Am Col Card"},{"key":"R74-24-20230601","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.amjcard.2006.06.051","article-title":"Comparison of 60-day mortality in hospitalized heart failure patients with versus without hypothermia","volume":"98","author":"Payvar","year":"2006","journal-title":"Am J Card"},{"key":"R75-24-20230601","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1388-9842(99)00024-0","article-title":"The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)","volume":"1","author":"Cleland","year":"1999","journal-title":"Eur J Heart Fail"},{"key":"R77-24-20230601","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2005.11.005","article-title":"Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Guideline","volume":"12","author":"Adams","year":"2006","journal-title":"J Card Fail"},{"key":"R78-24-20230601","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med"},{"key":"R79-24-20230601","doi-asserted-by":"crossref","first-page":"s89","DOI":"10.1097\/01.CCM.0000296272.68078.6B","article-title":"Diuretics: Still the mainstay of treatment","volume":"36","author":"Wang","year":"2008","journal-title":"Crit Care Med"},{"key":"R80-24-20230601","doi-asserted-by":"crossref","first-page":"L45","DOI":"10.1016\/S0024-3205(98)00265-3","article-title":"Torsemide inhibits aldosterone secretion in vitro","volume":"63","author":"Goodfriend","year":"1998","journal-title":"Life Sci"},{"key":"R81-24-20230601","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.hfc.2008.04.002","article-title":"Edema mechanisms in patients with heart failure and treatment options","volume":"4","author":"Sica","year":"2008","journal-title":"Heart Failure Clin"},{"key":"R82-24-20230601","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R83-24-20230601","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R84-24-20230601","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"key":"R85-24-20230601","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","article-title":"Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)","volume":"118","author":"Pitt","year":"2008","journal-title":"Circ"},{"key":"R87-24-20230601","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patient with acutely decompensated heart failure [published erratum in Circulation 111: 2274, 2005]","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"key":"R88-24-20230601","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.jacc.2006.03.013","article-title":"Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction","volume":"47","author":"Riter","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R89-24-20230601","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1097\/01.CCM.0000297161.41559.93","article-title":"Vasodilators I the management of acute heart failure","volume":"361","author":"Elkayam","year":"2008","journal-title":"Cri Care Med"},{"key":"R90-24-20230601","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.69.1.113","article-title":"Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine","volume":"69","author":"Liang","year":"1984","journal-title":"Circulation"},{"key":"R91-24-20230601","first-page":"38","article-title":"Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure [Abstract]","volume":"74","author":"Dies","year":"1986","journal-title":"Circulation"},{"key":"R92-24-20230601","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R94-24-20230601","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0735-1097(02)02134-4","article-title":"Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: A randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol and carvedilol","volume":"40","author":"Metra","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R95-24-20230601","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.CIR.95.6.1363","article-title":"Plasma adenosine levels increase in patient with chronic heart failure","volume":"97","author":"Funaya","year":"1997","journal-title":"Criculation"},{"key":"R96-24-20230601","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/hc1102.105264","article-title":"BG9717 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"key":"R97-24-20230601","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(99)00532-X","article-title":"Effect of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure","volume":"35","author":"Gottlieb","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R98-24-20230601","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R99-24-20230601","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensate heart failure: The SURVIVE randomized trial","volume":"297","author":"Mebazza","year":"2007","journal-title":"JAMA"},{"key":"R100-24-20230601","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1097\/01.CCM.0000296273.72952.39","article-title":"Inotropes in the management of acute heart failure","volume":"36","author":"Petersen","year":"2008","journal-title":"Crit Care Med"},{"key":"R101-24-20230601","first-page":"3362","article-title":"REVIVE II: Multicenter placebo-controlled trial of levosimendan on clinical status in acutely decompensated heart failure","volume":"112","author":"Packer","year":"2005","journal-title":"Circ"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-200912000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:05Z","timestamp":1786369145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-200912000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":93,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03150509","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}